News: PBP Probiotec Says Gross Margins Expected To Reverse Progressively Over Second Half

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Feb 24 (Reuters) - Probiotec (PBP) :

    • GROSS MARGINS EXPECTED TO REVERSE PROGRESSIVELY OVER SECOND HALF OF FY23
    • BOARD EXPECTS TO DELIVER SALES OF A$205M TO A$215M FOR FY23
    • BOARD EXPECTS TO DELIVER EBITDA OF A$34.5M TO A$36.0M FOR FY23
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.